Bristol-Myers Squibb BMY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's free cash flow?
- Bristol-Myers Squibb (BMY) reported free cash flow of $757M in Q1 2026.
- How has Bristol-Myers Squibb's free cash flow changed year-over-year?
- Bristol-Myers Squibb's free cash flow decreased by 55.3% year-over-year, from $1.69B to $757M.
- What is the long-term trend for Bristol-Myers Squibb's free cash flow?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's free cash flow has grown at a -4.2% compound annual growth rate (CAGR), from $15.23B to $12.85B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.